Clover Health appoints former Sen. Robert Torricelli and Dr. Brian Miller to board

CLOVER HEALTH INVESTMENTS, CORP. /DE

Senator Robert Torricelli appointed Class I director, Dr. Brian J. Miller Class III director, effective September 22, 2026.
Torricelli joins Audit Committee; Miller joins Clinical Committee; board now nine directors, filling two vacancies.
Each receives pro rata 2026 director retainer and $200,000 RSU prorated for service days through Dec 31, 2026.
Torricelli is former U.S. Senator (NJ) and Clover insurance subsidiary board member since 2022; Miller is MedPAC commissioner and Johns Hopkins hospitalist.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.